Global Research Trends and Hotspots Analysis of the Scientific Production of Amitriptyline: A Bibliometric Approach

Author:

Pereira Cristian dos Santos1ORCID,Cruz Jorddy Neves1ORCID,Ferreira Maria Karolina Martins1,Baia-da-Silva Daiane Claydes1ORCID,Fontes-Junior Eneas Andrade2ORCID,Lima Rafael Rodrigues1ORCID

Affiliation:

1. Laboratory of Functional and Structural Biology, Institute of Biological Sciences, Federal University do Pará, Belém 66075-110, Brazil

2. Laboratory of Pharmacology of Inflammation and Behavior, Federal University of Pará, Belém 66075-110, Brazil

Abstract

Amitriptyline was first introduced as a medication to treat depression. Over time, this substance has been used to treat other conditions, such as gastrointestinal disorders, fibromyalgia, neuropathic pain, and analgesia, among others. However, there are no published studies that provide a broad view of the possible motivations that have led to changes in the use of amitriptyline. In this study, we have identified the landscape of use for amitriptyline based on knowledge mapping of the 100 most-cited articles about this drug. We searched Web of Science Core Collection without time and language restrictions. We obtained 14,446 results, but we only used the 100 most-cited articles that had amitriptyline as the object of study. We collected the following information from each article: authors, country of the corresponding authors, year of publication, citation count, citation density (number of citations per year), and keywords. In addition, we seek to map in the chosen articles study design and research findings. We found that since 1980, the use of amitriptyline has expanded beyond depression, moving to off-label use to treat a variety of diseases and conditions, including post-herpetic neuralgia, neuropathic pain, primary fibrosis, fibromyalgia, and migraine, can be considered a drug with more clinical applicability than its original clinical indication.

Funder

Coordination for the Improvement of Higher Education Personnel

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Pró-Reitoria de Pesquisa e Pós-graduação from Federal University of Pará

Publisher

MDPI AG

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Reference122 articles.

1. Thour, A., and Marwaha, R. (2021). Amitriptyline, StatPearls Publishing.

2. World Health Organization (2023, July 19). WHO Model List of Essential Medicines. Available online: http://www.who.int/medicines/organization/par/edl/expcom13/eml13_en.pdf.

3. Classics in Chemical Neuroscience: Amitriptyline;McClure;ACS Chem. Neurosci.,2021

4. A Brief History of Antidepressant Drug Development: From Tricyclics to beyond Ketamine;Pereira;Acta Neuropsychiatr.,2018

5. Leucht, C., Huhn, M., and Leucht, S. (2011). Cochrane Database of Systematic Reviews, John Wiley & Sons, Ltd.

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3